|
Index of reports
> Cases resulting in other serious reactions (431)
> Cases with Blood Creatinine Increased (22)
Below is the selection of adverse event reports related to Diovan (Valsartan) that includes cases resulting in other serious reactions where reactions include blood creatinine increased.
Adverse event in 10 year old male receiving Diovan (Valsartan)
Reported by a individual with unspecified qualification from Japan on 2007-10-29
Patient: 10 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Blood Urea Increased, Headache, Superior Sagittal Sinus Thrombosis, Nephrotic Syndrome, Convulsion, Cerebral Infarction, Dehydration, Proteinuria, Oliguria, Oedema, Blood Creatinine Increased, Acute Prerenal Failure, Anuria, Influenza
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Acecol
Dosage: 2 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
End date: 2007-03-01
Bredinin
Dosage: 150 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
Diovan
Dosage: 80 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
End date: 2007-03-01
Neoral
Dosage: 140 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
End date: 2007-03-19
Predonine
Dosage: 40 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
Other drugs received by patient: Lipitor; Zyloric
Adverse event in 10 year old male receiving Diovan (Valsartan)
Reported by a individual with unspecified qualification from Japan on 2007-10-29
Patient: 10 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Blood Urea Increased, Headache, Superior Sagittal Sinus Thrombosis, Nephrotic Syndrome, Convulsion, Cerebral Infarction, Dehydration, Proteinuria, Oliguria, Oedema, Blood Creatinine Increased, Acute Prerenal Failure, Anuria, Influenza
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Acecol
Dosage: 2 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
End date: 2007-03-01
Bredinin
Dosage: 150 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
Diovan
Dosage: 80 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
End date: 2007-03-01
Neoral
Dosage: 140 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
End date: 2007-03-19
Predonine
Dosage: 40 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
Other drugs received by patient: Lipitor; Zyloric
Adverse event in female receiving Diovan (Valsartan)
Reported by a consumer/non-health professional from United States on 2007-10-05
Patient: female
Adverse reactions / side effects: Carotid Artery Occlusion, Blood Creatinine Increased
Suspect drug(s):
Diovan (Valsartan)
Adverse event in 72 year old male receiving Diovan (Valsartan)
Reported by a physician from United States on 2007-10-05
Patient: 72 year old male, weighing 106.1 kg (233.4 pounds)
Adverse reactions / side effects: Blood Pressure Increased, Tinnitus, Hyperkalaemia, Blood Potassium Increased, Bradycardia, Headache, Blood Creatinine Increased
Suspect drug(s):
Diovan
Dosage: 320 mg, qd, oral
Administration route: Oral
Indication: Hypertension
End date: 2007-08-01
Tekturna
Dosage: 150 mg, qd, oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-19
End date: 2007-07-20
Other drugs received by patient: Vytorin; Primidone; Glipizide; Lopid; Angiotensin II Antagonists (NO Ingredients / Substances)
Adverse event in 91 year old male receiving Diovan (Valsartan)
Reported by a pharmacist from Japan on 2007-07-30
Patient: 91 year old male
Adverse reactions / side effects: Blood Creatinine Increased
Adverse event resulted in: death
Suspect drug(s):
Diovan (Valsartan)
Adverse event in 68 year old male receiving Diovan (Valsartan)
Reported by a pharmacist from Japan on 2007-07-27
Patient: 68 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Intubation, Blood Albumin Decreased, X-RAY Abnormal, Haematocrit Decreased, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, Interstitial Lung Disease, Blood Sodium Increased, Blood Creatinine Increased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Blood Urea Increased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Blood Chloride Increased, Life Support, Protein Total Decreased, Albumin Globulin Ratio Decreased, Computerised Tomogram Abnormal, Mean Cell Volume Abnormal, Haemoglobin Decreased, Aspartate Aminotransferase Increased, Cell Marker, Platelet Count Decreased
Adverse event resulted in: disablity
Suspect drug(s):
Amiodarone HCL
Dosage: 400 mg/day
Administration route: Oral
Start date: 2007-04-24
End date: 2007-06-04
Diovan
Dosage: 80 mg, bid
Administration route: Oral
Indication: Hypertension
Start date: 2007-05-16
End date: 2007-05-16
Diovan
Dosage: 160 mg, bid
Administration route: Oral
Start date: 2007-05-17
End date: 2007-06-07
Adverse event in 62 year old female receiving Diovan (Valsartan)
Reported by a individual with unspecified qualification from Japan on 2007-07-27
Patient: 62 year old female
Adverse reactions / side effects: Myoglobinuria, Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Disseminated Intravascular Coagulation, Intubation, Hyperthermia Malignant, Pyrexia, Multi-Organ Failure, PO2 Decreased, Incontinence, Hypokinesia, C-Reactive Protein Increased, Dialysis, Musculoskeletal Stiffness, Blood Creatinine Increased, White Blood Cell Count Increased, Renal Failure Acute, Blood Alkaline Phosphatase Increased, Blood Pressure Increased, Metabolic Acidosis, Blood Urea Increased, Blood Lactate Dehydrogenase Increased, International Normalised Ratio Increased, Alanine Aminotransferase Increased, Respiratory Rate Decreased, Aspartate Aminotransferase Increased, Dehydration, Heart Rate Increased, Oliguria, Platelet Count Decreased, Depressed Level of Consciousness, Gait Disturbance, Blood Pressure Decreased
Adverse event resulted in: death
Suspect drug(s):
Biofermin
Administration route: Oral
Start date: 2006-07-18
End date: 2006-07-19
Diovan
Dosage: unk, unk
Administration route: Oral
Start date: 2003-01-01
Diovan
Dosage: 40 mg/day
Administration route: Oral
Start date: 2006-07-10
End date: 2006-07-19
Loxonin
Dosage: 60 mg/day
Administration route: Oral
Start date: 2006-07-18
End date: 2006-07-19
Mucosta
Dosage: 100 mg/day
Administration route: Oral
Start date: 2006-07-18
End date: 2006-07-19
Adverse event in 68 year old male receiving Diovan (Valsartan)
Reported by a pharmacist from Japan on 2007-07-26
Patient: 68 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Intubation, Blood Albumin Decreased, X-RAY Abnormal, Blood Albumin Increased, Haematocrit Decreased, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, Interstitial Lung Disease, RED Blood Cell Count Decreased, Blood Sodium Increased, Blood Creatinine Increased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Blood Chloride Increased, Life Support, Protein Total Decreased, Computerised Tomogram Abnormal, Mean Cell Volume Abnormal, Haemoglobin Decreased, Aspartate Aminotransferase Increased, Cell Marker, Platelet Count Decreased
Adverse event resulted in: disablity
Suspect drug(s):
Amiodarone HCL
Dosage: 400 mg/day
Administration route: Oral
Start date: 2007-04-24
End date: 2007-06-04
Diovan
Dosage: 80 mg, bid
Administration route: Oral
Indication: Hypertension
Start date: 2007-05-16
End date: 2007-05-16
Diovan
Dosage: 160 mg, bid
Administration route: Oral
Start date: 2007-05-17
End date: 2007-06-07
Adverse event in 67 year old female receiving Diovan (Valsartan)
Reported by a individual with unspecified qualification from Japan on 2007-07-23
Patient: 67 year old female
Adverse reactions / side effects: Myoglobinuria, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Intubation, Disseminated Intravascular Coagulation, Hyperthermia Malignant, Pyrexia, PO2 Decreased, Multi-Organ Failure, Hypokinesia, Incontinence, C-Reactive Protein Increased, Musculoskeletal Stiffness, Blood Creatinine Increased, Renal Failure Acute, White Blood Cell Count Increased, Blood Pressure Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, International Normalised Ratio Increased, Blood Lactate Dehydrogenase Increased, Respiratory Rate Decreased, Oliguria, Heart Rate Increased, Aspartate Aminotransferase Increased, Dehydration, Platelet Count Decreased, Depressed Level of Consciousness, Gait Disturbance, Blood Pressure Decreased
Adverse event resulted in: death
Suspect drug(s):
Diovan
Dosage: unk, unk
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 40 mg/day
Administration route: Oral
Start date: 2006-07-10
End date: 2006-07-19
Adverse event in male receiving Diovan (Valsartan)
Reported by a health professional (non-physician/pharmacist) from Brazil on 2007-07-11
Patient: male, weighing 73.0 kg (160.6 pounds)
Adverse reactions / side effects: Renal Disorder, Blood Cholesterol, Acute Myocardial Infarction, Blood Creatinine Increased
Suspect drug(s):
Diovan (Valsartan)
Other drugs received by patient: Euthyrox; Metoprolol Succinate; Monocordil; Aspirin; Lito; Plavix
Adverse event in 80 year old male receiving Diovan (Valsartan)
Reported by a physician from Japan on 2007-07-10
Patient: 80 year old male, weighing 52.0 kg (114.4 pounds)
Adverse reactions / side effects: Pyrexia, Haematocrit Decreased, RED Blood Cell Count Decreased, Fracture, Bone Marrow Failure, Blood Creatinine Increased, Blood Sodium Decreased, Lymphocyte Count Decreased, White Blood Cell Count Decreased, Blood Urea Increased, Urinary Tract Infection, Eosinophil Count Increased, Haemoglobin Decreased, Basophil Count Increased, Renal Failure, Blood Potassium Decreased, Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Diovan
Dosage: 20 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2002-02-01
End date: 2002-02-19
Diovan
Dosage: 40 mg/day
Administration route: Oral
Start date: 2002-02-20
End date: 2002-02-26
Diovan
Dosage: 20 mg/day
Administration route: Oral
Start date: 2002-02-27
End date: 2003-04-14
Diovan
Dosage: 80 mg/day
Administration route: Oral
Start date: 2003-04-15
End date: 2004-09-15
Diovan
Dosage: 120 mg/day
Administration route: Oral
Start date: 2004-09-16
End date: 2006-08-31
Diovan
Dosage: 160 mg/day
Administration route: Oral
Start date: 2006-09-01
End date: 2007-03-09
Diovan
Dosage: 40 mg/day
Administration route: Oral
Start date: 2007-04-03
End date: 2007-04-10
Fosmicin
Dosage: 1000 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2007-03-31
End date: 2007-04-02
Lasix
Dosage: 20 mg/day
Administration route: Oral
Indication: Oedema
Start date: 2007-04-05
Levofloxacin
Dosage: 100 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2007-03-29
End date: 2007-03-31
Omegacin
Dosage: 300 mg, unk
Indication: Pyrexia
Start date: 2007-03-27
End date: 2007-04-02
Vancomycin
Dosage: 1.5 g/day
Indication: Pyrexia
Start date: 2007-03-31
End date: 2007-03-31
Other drugs received by patient: Epogen; Humulin 70 / 30; Firstcin; Ferromia
Adverse event in 68 year old male receiving Diovan (Valsartan)
Reported by a pharmacist from Japan on 2007-07-06
Patient: 68 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Intubation, Blood Albumin Decreased, X-RAY Abnormal, Blood Albumin Increased, Haematocrit Decreased, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, Interstitial Lung Disease, RED Blood Cell Count Decreased, Blood Sodium Increased, Blood Creatinine Increased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Blood Chloride Increased, Life Support, Protein Total Decreased, Computerised Tomogram Abnormal, Mean Cell Volume Abnormal, Haemoglobin Decreased, Aspartate Aminotransferase Increased, Cell Marker, Platelet Count Decreased
Adverse event resulted in: disablity
Suspect drug(s):
Amiodarone HCL
Dosage: unk, unk
Administration route: Oral
Start date: 2007-04-24
End date: 2007-06-04
Diovan
Dosage: 80 mg, bid
Administration route: Oral
Indication: Hypertension
Start date: 2007-05-16
End date: 2007-05-16
Diovan
Dosage: 160 mg, bid
Administration route: Oral
Start date: 2007-05-17
End date: 2007-06-07
Adverse event in 68 year old male receiving Diovan (Valsartan)
Reported by a pharmacist from Japan on 2007-07-06
Patient: 68 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Intubation, Blood Albumin Decreased, X-RAY Abnormal, Blood Albumin Increased, Haematocrit Decreased, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, Interstitial Lung Disease, RED Blood Cell Count Decreased, Blood Sodium Increased, Blood Creatinine Increased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Blood Chloride Increased, Life Support, Protein Total Decreased, Computerised Tomogram Abnormal, Mean Cell Volume Abnormal, Haemoglobin Decreased, Aspartate Aminotransferase Increased, Cell Marker, Platelet Count Decreased
Adverse event resulted in: disablity
Suspect drug(s):
Amiodarone HCL
Dosage: unk, unk
Administration route: Oral
Start date: 2007-04-24
End date: 2007-06-04
Diovan
Dosage: 80 mg, bid
Administration route: Oral
Indication: Hypertension
Start date: 2007-05-16
End date: 2007-05-16
Diovan
Dosage: 160 mg, bid
Administration route: Oral
Start date: 2007-05-17
End date: 2007-06-07
Adverse event in 82 year old female receiving Diovan (Valsartan)
Reported by a individual with unspecified qualification from Japan on 2007-07-02
Patient: 82 year old female, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Hyperkalaemia, Feeling Cold, Blood Pressure Inadequately Controlled, Sinus Arrest, Blood Creatinine Increased, White Blood Cell Count Increased, Renal Failure Acute, Ventricular Extrasystoles, Blood Urea Increased, Muscular Weakness, Blood Potassium Increased, Blood Bicarbonate Decreased, Computerised Tomogram Abnormal, Tremor, Haemodialysis, Haemoglobin Decreased, Anorexia, Renal Hypertension, Electrocardiogram Abnormal, Bradycardia, Gait Disturbance, Blood Pressure Decreased, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Dosage: 25 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2002-11-18
End date: 2003-01-06
Diovan
Dosage: 80 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2002-12-01
Diovan
Start date: 2002-12-12
End date: 2003-01-06
Landel
Dosage: 60 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2001-02-27
End date: 2003-01-06
Landel
Dosage: 20 mg/day
Administration route: Oral
Start date: 2003-01-10
Odrik
Dosage: 2 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 1997-11-06
End date: 2003-01-06
Pimenol
Dosage: 100 mg/day
Administration route: Oral
Indication: Ventricular Arrhythmia
Start date: 1997-11-06
End date: 2003-01-06
Salobel
Dosage: 100 mg/day
Administration route: Oral
Indication: Hyperuricaemia
Start date: 1997-02-25
End date: 2003-01-06
Spironolactone
Dosage: unk, unk
Administration route: Oral
Indication: Hypertension
Start date: 2002-11-01
Trandolapril
Administration route: Oral
Indication: Hypertension
Start date: 1982-01-01
Adverse event in 80 year old male receiving Diovan (Valsartan)
Reported by a physician from Japan on 2007-06-28
Patient: 80 year old male, weighing 52.0 kg (114.4 pounds)
Adverse reactions / side effects: Pyrexia, Haematocrit Decreased, RED Blood Cell Count Decreased, Fracture, Bone Marrow Failure, Blood Creatinine Increased, Blood Sodium Decreased, Lymphocyte Count Decreased, White Blood Cell Count Decreased, Blood Urea Increased, Urinary Tract Infection, Eosinophil Count Increased, Haemoglobin Decreased, Basophil Count Increased, Renal Failure, Blood Potassium Decreased, Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Diovan
Dosage: 20 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2002-02-01
End date: 2002-02-19
Diovan
Dosage: 40 mg/day
Administration route: Oral
Start date: 2002-02-20
End date: 2002-02-26
Diovan
Dosage: 20 mg/day
Administration route: Oral
Start date: 2002-02-27
End date: 2003-04-14
Diovan
Dosage: 80 mg/day
Administration route: Oral
Start date: 2003-04-15
End date: 2004-09-15
Diovan
Dosage: 120 mg/day
Administration route: Oral
Start date: 2004-09-16
End date: 2006-08-31
Diovan
Dosage: 160 mg/day
Administration route: Oral
Start date: 2006-09-01
End date: 2007-03-09
Diovan
Dosage: 40 mg/day
Administration route: Oral
Start date: 2007-04-03
End date: 2007-04-10
Fosmicin
Dosage: 1000 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2007-03-31
End date: 2007-04-02
Lasix
Dosage: 20 mg/day
Administration route: Oral
Indication: Oedema
Start date: 2007-04-05
Levofloxacin
Dosage: 100 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2007-03-29
End date: 2007-03-31
Omegacin
Dosage: 300 mg, unk
Indication: Pyrexia
Start date: 2007-03-27
End date: 2007-04-02
Vancomycin HCL
Dosage: 1.5 g/day
Indication: Pyrexia
Start date: 2007-03-31
End date: 2007-03-31
Other drugs received by patient: Epogen; Humulin 70 / 30; Firstcin; Ferromia
Adverse event in 67 year old female receiving Diovan (Valsartan)
Reported by a individual with unspecified qualification from Japan on 2007-06-11
Patient: 67 year old female
Adverse reactions / side effects: Myoglobinuria, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Intubation, Disseminated Intravascular Coagulation, Hyperthermia Malignant, Pyrexia, PO2 Decreased, Multi-Organ Failure, Hypokinesia, Incontinence, C-Reactive Protein Increased, Musculoskeletal Stiffness, Blood Creatinine Increased, Renal Failure Acute, White Blood Cell Count Increased, Blood Pressure Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, International Normalised Ratio Increased, Blood Lactate Dehydrogenase Increased, Respiratory Rate Decreased, Oliguria, Heart Rate Increased, Aspartate Aminotransferase Increased, Dehydration, Platelet Count Decreased, Depressed Level of Consciousness, Gait Disturbance, Blood Pressure Decreased
Adverse event resulted in: death
Suspect drug(s):
Diovan
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 40 mg/day
Administration route: Oral
Start date: 2006-07-10
End date: 2006-07-19
Adverse event in 80 year old male receiving Diovan (Valsartan)
Reported by a physician from Japan on 2007-06-11
Patient: 80 year old male, weighing 52.0 kg (114.4 pounds)
Adverse reactions / side effects: Pyrexia, Haematocrit Decreased, RED Blood Cell Count Decreased, Fracture, Bone Marrow Failure, Blood Creatinine Increased, Blood Sodium Decreased, Lymphocyte Count Decreased, White Blood Cell Count Decreased, Blood Urea Increased, Urinary Tract Infection, Eosinophil Count Increased, Haemoglobin Decreased, Basophil Count Increased, Renal Failure, Blood Potassium Decreased, Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Diovan
Dosage: 20 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2002-02-01
End date: 2007-03-09
Diovan
Dosage: 40 mg/day
Administration route: Oral
Start date: 2007-04-03
End date: 2007-04-09
Fosmicin
Dosage: 1000 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2007-03-31
End date: 2007-04-02
Lasix
Dosage: 20 mg/day
Administration route: Oral
Indication: Oedema
Start date: 2007-04-05
End date: 2007-04-09
Levofloxacin
Dosage: 100 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2007-03-29
End date: 2007-03-31
Vancomycin HCL
Dosage: 1.5 g/day
Indication: Pyrexia
Start date: 2007-03-31
End date: 2007-03-31
Other drugs received by patient: Epogen; Humulin 70 / 30; Omegacin; Firstcin; Ferromia
Adverse event in receiving Diovan (Valsartan)
Reported by a physician from Japan on 2007-05-03
Patient:
Adverse reactions / side effects: Hyperkalaemia, Bradycardia, Blood Creatinine Increased
Suspect drug(s):
Diovan (Valsartan)
Adverse event in 66 year old male receiving Diovan (Valsartan)
Reported by a physician on 2007-04-04
Patient: 66 year old male
Adverse reactions / side effects: Blood Potassium Increased, Blood Creatinine Increased
Suspect drug(s):
Diovan
Dosage: daily dose:80mg
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: daily dose:40mg
Administration route: Oral
Norvasc
Dosage: daily dose:2.5mg
Administration route: Oral
Indication: Hypertension
Norvasc
Dosage: daily dose:5mg
Administration route: Oral
Other drugs received by patient: Bezatol - Slow Release; Allopurinol
Adverse event in male receiving Diovan (Valsartan)
Reported by a physician from Belgium on 2007-03-19
Patient: male
Adverse reactions / side effects: Coronary Artery Bypass, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Diovan
Dosage: 80 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2005-01-01
End date: 2006-10-01
Diovan
Dosage: 160 mg, qd
Administration route: Oral
Start date: 2006-10-01
End date: 2007-02-01
Other drugs received by patient: Lipitor; Asaflow; Hypan
Adverse event in 72 year old male receiving Diovan (Valsartan)
Reported by a consumer/non-health professional on 2007-03-13
Patient: 72 year old male
Adverse reactions / side effects: Glomerular Filtration Rate Decreased, Blood Creatinine Increased
Suspect drug(s):
Diovan (Valsartan)
Other drugs received by patient: Amlodipine
Adverse event in male receiving Diovan (Valsartan)
Reported by a physician from Belgium on 2007-01-23
Patient: male
Adverse reactions / side effects: Malaise, Blood Urea Increased, Dyspnoea, Blood Potassium Decreased, Cardiac Failure, Blood Uric Acid Increased, Muscular Weakness, Blood Creatinine Increased, Hypokalaemia
Suspect drug(s):
Diovan
Dosage: 160 mg, unk
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 160 mg
Administration route: Oral
Start date: 2006-12-01
Valsartan and Hydrochlorothiazide
Dosage: 160/25 mg
Administration route: Oral
Indication: Hypertension
Start date: 2006-12-01
End date: 2006-12-29
Other drugs received by patient: Lasix
|
